19 Dec 2018 16:56
EKF Diagnostics Holdings plc
("EKF" or the "Company")
PDMR dealing
EKF Diagnostics Holdings plc (AIM: EKF), the AIM-traded medical diagnostics business, announces that on 19 December 2018, the Company was notified by Mike Salter (President, Americas) that he has today purchased 125,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares").
EKF Diagnostics Holdings plc | www.ekfdiagnostics.com | |
Christopher Mills, Non-Executive Chairman | Tel: 029 2071 0570 | |
Julian Baines, CEO | ||
Richard Evans, FD & COO | ||
N+1 Singer (Nomad & Broker) | Tel: 020 7496 3000 | |
Aubrey Powell / George Tzimas / Carlo Spingardi (Corporate Finance) Tom Salvesen (Corporate Broking) | ||
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com | ||
Paul McManus/ Lianne Cawthorne | Mob: 07980 541 893 / 07584 391 303 | |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Mike Salter | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| President, Americas
| ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| EKF Diagnostics Holdings plc | ||||
b)
| LEI
| 213800DXTF3EAUK1AR05 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of 1p each ("Ordinary Shares")
ISIN Code: GB0031509804
| ||||
b)
| Nature of the transaction
| Purchase of shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
| n/a | ||||
e)
| Date of the transaction
| 19 December 2018 | ||||
f)
| Place of the transaction
| London Stock Exchange | ||||
Ekf Diagnostics (EKF)